-transparent.png){kind=logo}
Serum levels of placental protein 10 (PP10) were measured by radioimmunoassay in patients with trophoblastic (n = 23) and non-trophoblastic (n = 122) gynaecological tumours before, during and after treatment. Elevated levels (greater than 2.0 micrograms/l) were found in 96% of patients with an untreated trophoblastic tumour, and in 22%, 20% and 12% of patients with endometrial, cervical and ovarian carcinoma, respectively. After treatment the levels fell in patients with trophoblastic disease. Although PP10 may be tumour-associated in such cases, it is premature to assume any significance for PP10 as a tumour marker in clinical practice, because changes in serum hCG levels are much more informative.
A Tiitinen, and
G N Than, and
K Iino, and
H Halila, and
M Seppälä
January 1986,
Acta obstetricia et gynecologica Scandinavica,
A Tiitinen, and
G N Than, and
K Iino, and
H Halila, and
M Seppälä
November 1985,
British journal of obstetrics and gynaecology,
A Tiitinen, and
G N Than, and
K Iino, and
H Halila, and
M Seppälä
January 1987,
Archives of gynecology,
A Tiitinen, and
G N Than, and
K Iino, and
H Halila, and
M Seppälä
January 1986,
Acta obstetricia et gynecologica Scandinavica,
A Tiitinen, and
G N Than, and
K Iino, and
H Halila, and
M Seppälä
September 1986,
British journal of obstetrics and gynaecology,
A Tiitinen, and
G N Than, and
K Iino, and
H Halila, and
M Seppälä
January 1987,
Archives of gynecology and obstetrics,
A Tiitinen, and
G N Than, and
K Iino, and
H Halila, and
M Seppälä
January 1982,
Placenta,
A Tiitinen, and
G N Than, and
K Iino, and
H Halila, and
M Seppälä
January 1983,
Archives of gynecology,
A Tiitinen, and
G N Than, and
K Iino, and
H Halila, and
M Seppälä
August 1980,
Klinische Wochenschrift,
A Tiitinen, and
G N Than, and
K Iino, and
H Halila, and
M Seppälä
March 1968,
British journal of cancer,
